These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. L-DOPA and dopamine on skeletal muscle. Ferko AP; Calesnick B Res Commun Chem Pathol Pharmacol; 1971 Mar; 2(2):146-53. PubMed ID: 5149882 [No Abstract] [Full Text] [Related]
4. Pharmacodynamic application of L-dopa in cardiogenic shock. Lozano JR; Corday E; Carrasco HA; Lang TW; Meerbaum S Am Heart J; 1972 Mar; 83(3):351-9. PubMed ID: 5059578 [No Abstract] [Full Text] [Related]
5. Cardiovascular and renal actions of dopamine: potential clinical applications. Goldberg LI Pharmacol Rev; 1972 Mar; 24(1):1-29. PubMed ID: 4554480 [No Abstract] [Full Text] [Related]
6. , '- and , '-deuterium-labeled dopamine. Synthesis and pharmacologic actions. Perel JM; Dawson DK; Dayton PG; Goldberg LI J Med Chem; 1972 Jul; 15(7):714-6. PubMed ID: 5043869 [No Abstract] [Full Text] [Related]
7. The effect of various agents on the pressor response to dopa in the anesthetized dog. Pruss TP; McGill JS Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043 [No Abstract] [Full Text] [Related]
8. [Effect of ornid and phentolamine on the contractile function of heart in experimental myocardial infarction]. Shvab TIu Farmakol Toksikol; 1969; 32(5):564-6. PubMed ID: 5364669 [No Abstract] [Full Text] [Related]
9. Effect of dopamine on coronary vascular resistance and myocardial function. Nayler WG; McInnes I; Stone J; Carson V; Lowe TE Cardiovasc Res; 1971 Apr; 5(2):161-8. PubMed ID: 5579520 [No Abstract] [Full Text] [Related]
10. Trasicor: review of the pharmacology and clinical results. Fuccella LM S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429 [No Abstract] [Full Text] [Related]
11. Responses of the cardiac sympathetic receptors to various substances. Uchida Y; Kamisaka K; Ueda H Jpn Heart J; 1969 May; 10(3):225-42. PubMed ID: 4309393 [No Abstract] [Full Text] [Related]
12. Improvement of renal hemodynamics in endotoxin shock with dopamine, phenoxybenzamine and dextran. Shanbour LL; Lindeman RD; Archer LT; Tung SH; Hinshaw LB J Pharmacol Exp Ther; 1971 Feb; 176(2):383-8. PubMed ID: 5568782 [No Abstract] [Full Text] [Related]
13. Early and late effects of levodopa on the cardiovascular system in Parkinson's disease. A paired study. Ballantyne JP J Neurol Sci; 1973 May; 19(1):97-103. PubMed ID: 4715025 [No Abstract] [Full Text] [Related]
15. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions. Vatner SF; Millard RW; Higgins CB J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854 [No Abstract] [Full Text] [Related]
16. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs. Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053 [TBL] [Abstract][Full Text] [Related]
17. Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism. Robson RD Circ Res; 1971 Jun; 28(6):662-70. PubMed ID: 4325846 [No Abstract] [Full Text] [Related]
18. Dopamine generated from L-dopa: discrepancy between plasma levels and cardiac effects. Tjandramaga TB; Goldberg LI; Anton AH Proc Soc Exp Biol Med; 1973 Feb; 142(2):424-8. PubMed ID: 4689374 [No Abstract] [Full Text] [Related]
19. Effect of glucagon on heart muscle contractility. Hammer J; Sriussadaporn S; Freis ED Clin Pharmacol Ther; 1973; 14(1):56-61. PubMed ID: 4683072 [No Abstract] [Full Text] [Related]
20. [Ouabain-induced potentiation of pressor action of epinephrine]. Nakamura K Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):495-502. PubMed ID: 5529891 [No Abstract] [Full Text] [Related] [Next] [New Search]